Carisma Therapeutics, Inc. Common Stock
CARM
CARM: CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
moreShow CARM Financials
Recent trades of CARM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CARM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CARM's company Twitter account
Number of mentions of CARM in WallStreetBets Daily Discussion
Recent insights relating to CARM
Recent picks made for CARM stock on CNBC
ETFs with the largest estimated holdings in CARM
Flights by private jets registered to CARM